SPY332.11+2.05 0.62%
DIA272.00+3.59 1.34%
IXIC10,998.40+57.23 0.52%

Eli Lilly Reports Phase 3 Jardiance Trial Met Primary Endpoint; Trial Aimed At Reducing Risk Of Cardiovasvular Death, Hospitalization For Heart Failure In Adults With, Without Diabetes

Benzinga · -